(Q47266642)

English

The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients

scientific article published on 14 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic schizophrenia

1 reference

based on heuristic

inferred from title

Gavin P. Reynolds

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

author name string

Olga O Yevtushenko

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

Sarah Gordon

3

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

Belen Arranz

4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

Luis San

5

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

Luis San

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

Stephen J Cooper

7

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

publication date

14 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

16

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

1421-1425

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

The genetics of obesity: FTO leads the way.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001435

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1461145712001435

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23236985

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47266642&oldid=2148404958"